Three drug makers are looking into buying Pfizer's branded-generics drug business, according to published reports.
McKesson may take another bite of the Celesio apple, suggested Sterne Agee analyst Greg Bolan in a note published Monday.
McKesson on Monday announced that it was unsuccessful in reaching the 75% completion condition in its offer for the outstanding shares and convertible bonds of Celesio.
Diplomat has acquired a hemophilia-focused specialty pharmacy based in Connecticut, the specialty pharmacy company said Monday.
Target is offering free credit monitoring for a year for customers who shop at its stores, the mass merchandise retailer said Monday.
Merck on Monday reported on its intent to explore strategic options for its animal health and consumer care businesses.
Kmart's same-store sales have taken a tumble this quarter as its parent company says it is continuing to focus on transforming itself into a retailer focused on members of its loyalty card program.
The board of directors of Walgreens on Thursday declared a regular quarterly dividend of 31.5 cents per share, a 14.5% increase over the year-ago dividend.
Customers' mailing addresses, names, phone numbers and email addresses were among the data stolen as part of a massive breach of payment card data at Target, the mass merchandise retailer said Friday.
Forest Labs will buy privately owned drug maker Aptalis for $2.9 billion, Forest said Thursday.